Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sales/Fixed Asset

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Sales/Fixed Asset(x) 2.772.742.942.971.44

What is the latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS ?

The latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS is 2.77 based on Mar2024 Consolidated results.
Year Sales/Fixed Asset
Mar20242.77
Mar20232.74
Mar20222.94
Mar20212.97
Mar20201.44

How is Sales/Fixed Asset of GLENMARK PHARMACEUTICALS Trending?

Years Sales/Fixed Asset % Change
Mar2024 2.77
1.09
Mar2023 2.74
-6.80
Mar2022 2.94
-1.01
Mar2021 2.97
106.25
Mar2020 1.44 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Sales/Fixed Asset ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,844.5 Cr 22.5% 32.4% 60.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,533.0 Cr 3.6% 2.5% 6.2% Stock Analytics
DIVIS LABORATORIES ₹180,215.0 Cr -2.9% 1.5% 48.1% Stock Analytics
CIPLA ₹120,428.0 Cr -0.1% -2.4% -1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹116,410.0 Cr 2.5% 4.9% 15.2% Stock Analytics
DR REDDYS LABORATORIES ₹105,253.0 Cr -0.7% -6.4% -5.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

22.5%

32.4%

60.4%

SENSEX

-1.4%

1.8%

3.3%


You may also like the below Video Courses